您的当前位置：首页 > 行业数据 > Danuglipron针对糖尿病患者的IIb期临床、以及每日一次口服50mg司美格鲁肽安全性数据对比

Danuglipron针对糖尿病患者的IIb期临床、以及每日一次口服50mg司美格鲁肽安全性数据对比

行业数据

下载图片

原图定位

同报告图片

/ 4

Danuglipron针对糖尿病患者的IIb期临床、以及每日一次口服50mg司美格鲁肽安全性数据对比_第1页

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